MoneyWorks4Me

Clarification sought from Aurobindo Pharma

05 Mar 2018 Evaluate

The Exchange has sought clarification from Aurobindo Pharma on March 05, 2018 with reference to news flashed on www.moneycontrol.com dated March 05, 2018 quoting ‘US FDA observations - Aurobindo Unit 4 inspected by US FDA from February 12-20 and issues 9 observations.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..